Draft of clinical guidelines for the diagnosis and treatment of differentiated thyroid cancer in adult patients

The article presents a draft of clinical recommendations for the diagnosis and treatment of differentiated thyroid cancer in adult patients, which provides a modern examination algorithm, discusses the basic principles of laboratory, instrumental diagnostics and treatment approaches.

[1]  R. Chernikov,et al.  Targeted therapy of anaplastic thyroid cancer , 2023, Head and Neck Tumors (HNT).

[2]  A. Gianoukakis,et al.  A randomized study to evaluate the safety and efficacy of two dosages of lenvatinib – 18 and 24 mg – in patients with radioiodrefract differentiated thyroid cancer , 2022, Head and Neck Tumors (HNT).

[3]  J. Soria,et al.  Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  V. Krylov,et al.  Radioiodine Ablation for Thyroid Cancer. Historical and Modern Aspects. Literature Review , 2021, Journal of oncology: diagnostic radiology and radiotherapy.

[5]  M. Kerin,et al.  Radioiodine Remnant Ablation for Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis. , 2021, JAMA otolaryngology-- head & neck surgery.

[6]  Frederick D. Grant,et al.  A JOINT STATEMENT FROM THE AMERICAN THYROID ASSOCIATION. , 2021, Thyroid : official journal of the American Thyroid Association.

[7]  T. Giordano,et al.  2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. , 2021, Thyroid : official journal of the American Thyroid Association.

[8]  A. A. Semenov,et al.  TREATMENT OF BRAFV600E POSITIVE ANAPLASTIC THYROID CARCINOMA: CASE REPORT , 2020 .

[9]  M. Beheshti,et al.  Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain , 2020, Journal of clinical medicine.

[10]  Mark Robson,et al.  Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  L. Jia,et al.  Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway. , 2020, Life sciences.

[12]  K. Bible,et al.  Bone metastases in thyroid cancer , 2020, Journal of bone oncology.

[13]  M. Papotti,et al.  Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  M. Luster,et al.  Management Guidelines for Children With Thyroid Nodules and Differentiated Thyroid Cancer , 2018, Pediatrics.

[15]  F. Vaisman,et al.  The Impact of Zoledronic Acid and Radioactive Iodine Therapy on Morbi-Mortality of Patients with Bone Metastases of Thyroid Cancer Derived from Follicular Cells , 2018, European Thyroid Journal.

[16]  M. Brose,et al.  Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial , 2018, Head and neck tumors (HNT).

[17]  W. Knoefel,et al.  Measurement of Basal Serum Calcitonin for the Diagnosis of Medullary Thyroid Cancer , 2017, Hormone and Metabolic Research.

[18]  E. Cibas,et al.  The 2017 Bethesda System for Reporting Thyroid Cytopathology. , 2017, Journal of the American Society of Cytopathology.

[19]  P. Trimboli,et al.  Measurement of thyroglobulin, calcitonin, and PTH in FNA washout fluids , 2017, Clinical chemistry and laboratory medicine.

[20]  J. Utikal,et al.  Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  K. Hess,et al.  Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. , 2017, Thyroid : official journal of the American Thyroid Association.

[22]  J. Won,et al.  Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma. , 2016, Thyroid.

[23]  C. Reiners,et al.  Endogenous TSH levels at the time of 131I ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  T. Jacks,et al.  p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer , 2014, Proceedings of the National Academy of Sciences.

[25]  E. Alexander,et al.  The importance, and important limitations, of ultrasound imaging for evaluating thyroid nodules. , 2013, JAMA internal medicine.

[26]  M. Friedrich-Rust,et al.  Interobserver Agreement of Thyroid Imaging Reporting and Data System (TIRADS) and Strain Elastography for the Assessment of Thyroid Nodules , 2013, PloS one.

[27]  D. Loeb,et al.  Beyond Palliation: Therapeutic Applications of 153Samarium-EDTMP , 2013, Clinical & experimental pharmacology.

[28]  A. Gawande,et al.  Thyroid nodule size and prediction of cancer. , 2013, The Journal of clinical endocrinology and metabolism.

[29]  E. Ding,et al.  Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. , 2012, The Journal of clinical endocrinology and metabolism.

[30]  J. Copland,et al.  Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[31]  B. Biondi,et al.  Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. , 2010, Thyroid : official journal of the American Thyroid Association.

[32]  Jack Yang,et al.  Fine‐needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations , 2007, Cancer.

[33]  Gerard M Doherty,et al.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.

[34]  R. Golouh,et al.  Effect of primary treatment on survival in anaplastic thyroid carcinoma. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[35]  S. Sherman,et al.  Prognosis and treatment of brain metastases in thyroid carcinoma. , 1997, The Journal of clinical endocrinology and metabolism.

[36]  T. Uruno,et al.  Thyroid Lobectomy for Papillary Thyroid Cancer: Long-term Follow-up Study of 1,088 Cases , 2013, World Journal of Surgery.

[37]  A. Pontecorvi,et al.  Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. , 1998, Thyroid : official journal of the American Thyroid Association.